Networks of Innovation offers an historical perspective on the manner in which private-sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp and Dohme, which acquired Mulford in 1929, and upon Merck & Co Inc., which merged with Sharp and Dohme in 1953. By surveying a century of innovation in biologicals, the authors are able to analyze the conditions that either promoted or prevented creative changes in this important industry. They show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad. This is the first such history to draw exclusively on sources internal to Merck, one of the world's leading innovators in modern vaccines and pharmaceuticals.
"synopsis" may belong to another edition of this title.
'The work is admirably referenced and will be of value to all who take an interest in the field of biologicals. It will repay careful reading by those involved in the management of innovation in the pharmaceutical industry.' John Hunt, The Pharmaceutical Journal
Networks of Innovation offers an historical perspective on how private sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines, and how their activities were related to complex, evolving networks of scientific, governmental, and medical institutions.
"About this title" may belong to another edition of this title.
£ 6.92 shipping from France to United Kingdom
Destination, rates & speeds£ 32.68 shipping from U.S.A. to United Kingdom
Destination, rates & speedsSeller: Ammareal, Morangis, France
Hardcover. Condition: Très bon. Ancien livre de bibliothèque. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Very good. Former library book. Ammareal gives back up to 15% of this item's net price to charity organizations. Seller Inventory # E-952-098
Quantity: 1 available
Seller: Better World Books, Mishawaka, IN, U.S.A.
Condition: Good. Used book that is in clean, average condition without any missing pages. Seller Inventory # 3320505-6
Quantity: 1 available
Seller: Better World Books, Mishawaka, IN, U.S.A.
Condition: Very Good. Former library book; may include library markings. Used book that is in excellent condition. May show signs of wear or have minor defects. Seller Inventory # GRP87448336
Quantity: 1 available
Seller: Antiquariaat Die Sammlung, Amsterdam Zuidoost, Netherlands
Hardcover. Condition: Fine. Dust Jacket Condition: Fine. 1st Edition. XI, 273 p. First edition in hardback with dustjacket. Seller Inventory # 2-2 540
Quantity: 1 available
Seller: Wonder Book, Frederick, MD, U.S.A.
Condition: Good. Good condition. Very Good dust jacket. A copy that has been read but remains intact. May contain markings such as bookplates, stamps, limited notes and highlighting, or a few light stains. Seller Inventory # T09Q-01350
Quantity: 1 available
Seller: Wonder Book, Frederick, MD, U.S.A.
Condition: Very Good. Very Good condition. Very Good dust jacket. A copy that may have a few cosmetic defects. May also contain light spine creasing or a few markings such as an owner's name, short gifter's inscription or light stamp. Seller Inventory # K02K-01046
Quantity: 1 available
Seller: MW Books Ltd., Galway, Ireland
First Edition. Near fine cloth copy in a near-fine, very slightly edge-nicked and dust-dulled dust-wrapper. Remains particularly well-preserved overall; tight, bright, clean and strong. Physical description: xi, 273 pages; 24 cm. Subjects: Merck, Sharp & Dohme International History; H. K. Mulford Company History; Sharp & Dohme (Firm) History; Merck & Co. History; Merck, Sharp and Dohme (Firm); Vaccines History; Vaccines industry History; Vaccination United States Research History; Pharmaceutical industry United States History; Vaccines. 1 Kg. Seller Inventory # 417005
Quantity: 1 available
Seller: MW Books, New York, NY, U.S.A.
First Edition. Near fine cloth copy in a near-fine, very slightly edge-nicked and dust-dulled dust-wrapper. Remains particularly well-preserved overall; tight, bright, clean and strong. Physical description: xi, 273 pages; 24 cm. Subjects: Merck, Sharp & Dohme International History; H. K. Mulford Company History; Sharp & Dohme (Firm) History; Merck & Co. History; Merck, Sharp and Dohme (Firm); Vaccines History; Vaccines industry History; Vaccination United States Research History; Pharmaceutical industry United States History; Vaccines. 1 Kg. Seller Inventory # 417005
Quantity: 1 available
Seller: SecondSale, Montgomery, IL, U.S.A.
Condition: Good. Item in good condition. Textbooks may not include supplemental items i.e. CDs, access codes etc. Seller Inventory # 00028820076
Quantity: 1 available
Seller: Jeff Weber Rare Books, Neuchatel, NEUCH, Switzerland
8vo. 273, [1] pp. Index. Blue silver-stamped cloth, dust jacket. INSCRIBED by both authors, with Christmas card "Lots of love to the family, Jane and Lou". Fine. ISBN: 0521563089 "Networks of Innovation offers an historical perspective on the manner in which private-sector organizations have acquired, sustained, and periodically lost the ability to develop, manufacture, and market new serum antitoxins and vaccines. The primary focus is on the H. K. Mulford Company, on Sharp and Dohme, which acquired Mulford in 1929, and upon Merck & Co Inc., which merged with Sharp and Dohme in 1953. By surveying a century of innovation in biologicals, the authors are able to analyze the conditions that either promoted or prevented creative changes in this important industry. They show how the activities of these three commercial enterprises were related to a series of complex, evolving networks of scientific, governmental, and medical institutions in the United States and abroad. This is the first such history to draw exclusively on sources internal to Merck, one of the world's leading innovators in modern vaccines and pharmaceuticals." âÂÂ" Cambridge University Press. Seller Inventory # PW1273
Quantity: 1 available